Abbott (ABT) Initiates Absorb BVS vs. XIENCE PRIME Evaluation Trial

Go back to Abbott (ABT) Initiates Absorb BVS vs. XIENCE PRIME Evaluation Trial
Abbott Laboratories (NYSE: ABT) Delayed: 116.64 +2.50 (2.19%)
Previous Close $114.14    52 Week High $46.38 
Open $114.02    52 Week Low $36.00 
Day High $116.66    P/E 77.76 
Day Low $113.45    EPS $1.50 
Volume 10,931,169